Its essential to discuss any potential interactions with your healthcare provider.
The fact that retatrutide addresses multiple cardiovascular risk factors simultaneouslyweight, blood pressure, lipids, and inflammationsuggests it could have profound impacts on long-term health outcomes
Microbial trimethylamine (TMA), converted in the liver to trimethylamine-N-oxide (TMAO), further links gut ecology to cardiometabolic injury by affecting cholesterol trafficking, endothelial reactivity, and platelet responses
Retatrutide is an investigational drug still in clinical development and not approved by the FDA
In this small case series, we found that the initiation of semaglutide soon after the diagnosis of type 1 diabetes was associated with the elimination of prandial insulin in all 10 patients and basal insulin in most of the patients, along with increased C-peptide levels and better glycemic control during the year of observation